HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hye Suk Lee Selected Research

Dronedarone

2/2021Pharmacokinetic interaction between dronedarone and ticagrelor following oral administration in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hye Suk Lee Research Topics

Disease

24Neoplasms (Cancer)
03/2024 - 02/2011
7Inflammation (Inflammations)
06/2023 - 01/2018
7Reperfusion Injury
04/2007 - 10/2002
6Carcinogenesis
01/2022 - 11/2015
5Infections
01/2022 - 01/2012
5Breast Neoplasms (Breast Cancer)
10/2020 - 07/2014
4Melanoma (Melanoma, Malignant)
01/2024 - 12/2012
4Gout
01/2022 - 01/2018
4Colonic Neoplasms (Colon Cancer)
12/2021 - 01/2013
4Ischemia
02/2004 - 10/2002
3Rheumatoid Arthritis
01/2022 - 01/2018
3Body Weight (Weight, Body)
11/2021 - 06/2011
3Skin Neoplasms (Skin Cancer)
01/2020 - 12/2012
3Lung Neoplasms (Lung Cancer)
01/2019 - 02/2014
3Asthma (Bronchial Asthma)
04/2017 - 09/2009
2Atopic Dermatitis (Atopic Eczema)
06/2023 - 11/2021
2Poisoning
04/2022 - 07/2018
2Obesity
11/2021 - 01/2021
2Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021 - 01/2020
2Arthritis (Polyarthritis)
02/2021 - 01/2018
2Mitochondrial Diseases (Mitochondrial Disease)
02/2021 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 06/2014
2Acne Vulgaris
09/2020 - 12/2018
2Neoplastic Cell Transformation
10/2015 - 02/2014
2Diabetic Neuropathies (Diabetic Neuropathy)
07/2014 - 01/2013
2Peripheral Nervous System Diseases (PNS Diseases)
07/2014 - 01/2013
1Prostatic Neoplasms (Prostate Cancer)
04/2024
1Bites and Stings (Sting)
06/2023
1Liver Failure
04/2023
1Non-alcoholic Fatty Liver Disease
01/2023
1Fibrosis (Cirrhosis)
01/2023
1Ankylosing Spondylitis
01/2022
1Dermatitis
11/2021
1Skin Diseases (Skin Disease)
11/2021

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
04/2024 - 12/2012
11InflammasomesIBA
01/2023 - 01/2018
4Epidermal Growth Factor (EGF)IBA
02/2021 - 12/2012
4Peptides (Polypeptides)IBA
10/2020 - 07/2014
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2020 - 07/2014
4Organic Anion TransportersIBA
10/2020 - 07/2014
4AnionsIBA
10/2020 - 07/2014
4AgarIBA
04/2019 - 12/2012
4Neuroprotective AgentsIBA
02/2004 - 10/2002
3Mitogen-Activated Protein KinasesIBA
01/2022 - 02/2014
3Uric Acid (Urate)IBA
02/2021 - 01/2018
3CationsIBA
10/2020 - 07/2014
3CytochromesIBA
10/2020 - 10/2003
3AntioxidantsIBA
10/2018 - 04/2017
3Guanidine (Guanidine Nitrate)FDA Link
04/2007 - 11/2005
2AllergensIBA
06/2023 - 11/2021
2DNA (Deoxyribonucleic Acid)IBA
06/2023 - 03/2020
2InterferonsIBA
06/2023 - 01/2020
2amatoxinIBA
04/2023 - 04/2022
2loganinIBA
01/2023 - 02/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2020
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2021 - 04/2019
2kaempferolIBA
12/2021 - 01/2018
2celastrolIBA
11/2021 - 01/2019
2Pattern Recognition ReceptorsIBA
11/2021 - 01/2020
2CytokinesIBA
11/2021 - 01/2019
2LignansIBA
02/2021 - 12/2014
2Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
09/2020 - 02/2015
2EnzymesIBA
09/2020 - 02/2015
2Adenosine Triphosphate (ATP)IBA
01/2020 - 01/2019
2Glutathione (Reduced Glutathione)IBA
01/2020 - 07/2017
2NLR ProteinsIBA
06/2019 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2019 - 10/2015
2magnolinIBA
01/2019 - 02/2014
2Pyrin Domain-Containing 3 Protein NLR FamilyIBA
01/2019 - 12/2018
2TOR Serine-Threonine KinasesIBA
01/2019 - 10/2015
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2017 - 02/2015
2verprosideIBA
04/2017 - 09/2009
2DA-9801IBA
07/2014 - 01/2013
2(5- (2- methoxy- 5- chloro- 5- phenyl)furan- 2- ylcarbonyl)guanidineIBA
04/2007 - 01/2006
2Cardiotonic Agents (Cardiac Stimulants)IBA
04/2007 - 11/2005
2furanIBA
04/2007 - 01/2006
2KR-31543IBA
02/2004 - 10/2002
2BenzopyransIBA
02/2004 - 10/2002
2N''- cyano- N- (6- amino- 3,4- dihydro- 3- hydroxy- 2- methyl- 2- dimethoxymethyl- 2H- benzopyran- 4- yl)- N'- benzylguanidineIBA
10/2003 - 10/2002
1Docetaxel (Taxotere)FDA Link
04/2024
1A-Form DNA (A-DNA)IBA
03/2024
1Melanocyte-Stimulating Hormones (MSH)IBA
01/2024
1ChemokinesIBA
06/2023
1ChromatinIBA
06/2023
1RNA Polymerase II (RNA Polymerase B)IBA
04/2023
1Alpha-AmanitinIBA
04/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023
1Mitogen-Activated Protein Kinase 6IBA
01/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021
1Interleukin-13IBA
11/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2021
1Thymic Stromal LymphopoietinIBA
11/2021
1Interleukin-4 (Interleukin 4)IBA
11/2021
1IFIH1 Interferon-Induced HelicaseIBA
11/2021
1Interleukin-5 (Interleukin 5)IBA
11/2021
1fargesinIBA
02/2021
1CyclinsIBA
02/2021

Therapy/Procedure

9Therapeutics
03/2024 - 01/2012
4Oral Administration
02/2021 - 01/2018